临床药师参与1例滤泡性淋巴瘤合并丙型肝炎患者免疫化疗方案制订的病例分析(4)
[ 6 ] ZAKY AH，BAKRY R，EL-SAYED MI，et al. Impact of treatment-related toxicity on outcome of HCV-positive diffuse large B-cell lymphoma in rituximab era[J]. Hematology，2014，19(7)：412-416.
[ 7 ] SALAH-ELDIN MA，EBRAHIM MA，EL-SADDA W. Clinical outcome of HCV-positive patients with diffuse large B-cell lymphoma treated with rituximab-based chemotherapy[J]. Ann Hematol，2014，93(11)：1903-1911.
[ 8 ] VALLISA D，BERNUZZI P，ARCAINI L，et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related，low-grade，b-cell，non-hodgkin’s lymphoma：a multicenter italian experience[J]. J Clin Oncol，2005，23(3)：468-473.
[ 9 ] ARCAINI L，MERLI M，VOLPETTI S，et al. Indolent B- cell lymphomas associated with HCV infection：clinical and virological features and role of antiviral therapy[J]. Clin Dev Immunol，2012.DOI：10.1155/2012/638185.
[10] LA MURA V，DE RENZO A，PERNA F，et al. Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin’s lymphoma[J]. J Hepatol，2008，49(4)：557-563.
[11] VISCO C，FINOTTO S. Hepatitis C virus and diffuse lar- ge B-cell lymphoma：Pathogenesis，behavior and treatment[J]. World J Gastroenterol，2014，20(32)：11054-11061.
[12] 张海英，任晓蕾，李玉珍.临床药师参与1例术后感染患者的抗感染治疗实践[J].中国药房，2012，23(30)：2870-2872.
[13] 金秉巾.臨床药师参与1例扁桃体癌患者化疗方案的制订和药学监护[J].中国药房，2017，28(26)：3723-3725.
(收稿日期：2018-01-11 修回日期：2018-03-15)
(编辑：邹丽娟), 百拇医药(徐姗 苏丹)
[ 7 ] SALAH-ELDIN MA，EBRAHIM MA，EL-SADDA W. Clinical outcome of HCV-positive patients with diffuse large B-cell lymphoma treated with rituximab-based chemotherapy[J]. Ann Hematol，2014，93(11)：1903-1911.
[ 8 ] VALLISA D，BERNUZZI P，ARCAINI L，et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related，low-grade，b-cell，non-hodgkin’s lymphoma：a multicenter italian experience[J]. J Clin Oncol，2005，23(3)：468-473.
[ 9 ] ARCAINI L，MERLI M，VOLPETTI S，et al. Indolent B- cell lymphomas associated with HCV infection：clinical and virological features and role of antiviral therapy[J]. Clin Dev Immunol，2012.DOI：10.1155/2012/638185.
[10] LA MURA V，DE RENZO A，PERNA F，et al. Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin’s lymphoma[J]. J Hepatol，2008，49(4)：557-563.
[11] VISCO C，FINOTTO S. Hepatitis C virus and diffuse lar- ge B-cell lymphoma：Pathogenesis，behavior and treatment[J]. World J Gastroenterol，2014，20(32)：11054-11061.
[12] 张海英，任晓蕾，李玉珍.临床药师参与1例术后感染患者的抗感染治疗实践[J].中国药房，2012，23(30)：2870-2872.
[13] 金秉巾.臨床药师参与1例扁桃体癌患者化疗方案的制订和药学监护[J].中国药房，2017，28(26)：3723-3725.
(收稿日期：2018-01-11 修回日期：2018-03-15)
(编辑：邹丽娟), 百拇医药(徐姗 苏丹)